Personalized Treatment in Oncological Therapeutics: Unlocking Targeted Cancer Treatment

Abstract

Personalized medicine has emerged as a transformative approach tailoring cancer therapeutics for individual patients, encompassing unique genetic, molecular, and clinical characteristics. Conventional "one-size-fits-all” treatments have endorsed more focused and precise approaches, with ultimate advancement in genomics, biomarker identification, and cutting-edge technologies, including artificial intelligence (AI), CRISPR gene editing, and nanoparticulate system approaches. Personalized therapeutic approaches, including genomic and molecular profiling, pharmacogenomics, epigenetic modulation, and immunotherapy, additionally address cost, tumor heterogeneity, and ethical concerns. Despite notable progression, tumor heterogeneity, complex/concomitant molecular modulations, along limited access to genomic diagnostics, suggested further refining of therapeutic assessments via CRISPR gene management and artificial intelligence. Furthermore, recent clinical studies and future directives provide possible suggestions regarding personalized medicines' potential for the establishment of a gold standard Oncological treatment with improved patient outcomes and revolutionized oncologicalmanagement at dual clinical and systemic levels..